Pharmacoeconomic review report: Nitisinone (Nitisinone tablets) (Cycle Pharmaceuticals Ltd.) indication : for the treatment of patients with hereditary tyrosinemia type 1 in combination with dietary restriction of tyrosine and phenylalanine

Nitisinone (Nitisinone Tablets) is indicated for the treatment of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine. Nitisinone Tablets are available in 2 mg, 5 mg, and 10 mg strengths. The submitted price of nitisinone is based on dose: 2 mg...

Full description

Bibliographic Details

Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2018, August 2018
Series:	CADTH common drug review
Subjects:	Enzyme Inhibitors / Therapeutic Use Canada Tyrosinemias / Drug Therapy Enzyme Inhibitors / Economics Cost-benefit Analysis
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK539410
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa